Coordinate Nodal and BMP inhibition directs Baf60c-dependent cardiomyocyte commitment.
Wenqing Cai, Sonia Albini, Ke Wei, Erik Willems, Rosa M Guzzo, Masanao Tsuda, Lorenzo Giordani, Sean Spiering, Leo Kurian, Gene W Yeo, Pier Lorenzo Puri, Mark Mercola
Genes & development · 2013 · Vol. 27 (21) · pp. 2332-44
Abstract
A critical but molecularly uncharacterized step in heart formation and regeneration is the process that commits progenitor cells to differentiate into cardiomyocytes. Here, we show that the endoderm-derived dual Nodal/bone morphogenetic protein (BMP) antagonist Cerberus-1 (Cer1) in embryonic stem cell cultures orchestrates two signaling pathways that direct the SWI/SNF chromatin remodeling complex to cardiomyogenic loci in multipotent (KDR/Flk1+) progenitors, activating lineage-specific transcription. Transient inhibition of Nodal by Cer1 induces Brahma-associated factor 60c (Baf60c), one of three Baf60 variants (a, b, and c) that are mutually exclusively assembled into SWI/SNF. Blocking Nodal and BMP also induces lineage-specific transcription factors Gata4 and Tbx5, which interact with Baf60c. siRNA to Cer1, Baf60c, or the catalytic SWI/SNF subunit Brg1 prevented the developmental opening of chromatin surrounding the Nkx2.5 early cardiac enhancer and cardiomyocyte differentiation. Overexpression of Baf60c fully rescued these deficits, positioning Baf60c and SWI/SNF function downstream from Cer1. Thus, antagonism of Nodal and BMP coordinates induction of the myogenic Baf60c variant and interacting transcription factors to program the developmental opening of cardiomyocyte-specific loci in chromatin. This is the first demonstration that cues from the progenitor cell environment direct the subunit variant composition of SWI/SNF to remodel the transcriptional landscape for lineage-specific differentiation.
Funding 14 grants
| Grant | Funder |
|---|---|
| P30 CA030199 | NCI NIH HHS (United States) |
| R01 NS075449 | NINDS NIH HHS (United States) |
| R37HL050502 | NHLBI NIH HHS (United States) |
| P30AR061303 | NIAMS NIH HHS (United States) |
| R01 HL108176 | NHLBI NIH HHS (United States) |
| R01 AR056712 | NIAMS NIH HHS (United States) |
| R01AR056712 | NIAMS NIH HHS (United States) |
| P30 AR061303 | NIAMS NIH HHS (United States) |
| R33HL088266 | NHLBI NIH HHS (United States) |
| P30CA030199 | NCI NIH HHS (United States) |
| R33 HL088266 | NHLBI NIH HHS (United States) |
| R01AR052779 | NIAMS NIH HHS (United States) |
| R01HL108176 | NHLBI NIH HHS (United States) |
| R01 AR052779 | NIAMS NIH HHS (United States) |